Who invested in Phagenesis

7 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$110Mraised across 7 rounds since 2010, from 7 sources

$3.1MSeries A$9.2MSeries B$17MSeries B$42MSeries D$14MRound$13MRound$12MRound

Latest round: Round, $12MApr 2026
Biggest round: $42MSeries D · Mar 2024
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201020132016201920222025

$3.1MSeries A$9.2MSeries B$17MSeries B$42MSeries D$14MRound$13MRound$12MRound

First round: Series A, $3.1M
Biggest round: $42M
Usual gap between rounds: 13 months

The rounds

Apr 2026
Round$12M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Aug 2025
Round$13M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Aug 2024
Round$14M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Mar 2024
Series D$42M2 new
- EQT Life Sciences
- Northern Gritstone
Source recorded
May 2013
Series B$17M1 returning
- Inventages Venture Capital
Reported by finsmes.com
Oct 2011
Series B$9.2M1 new
- Inventages Venture Capital
Reported by finsmes.com
Sept 2010
Series A$3.1M
No investor was named in the report.
Reported by biotech-intelligence.com

Funding filed with regulators

Phagenesis filed 3 raises, $39M in all. Filings say how much was sold and to how many investors; they never name the investors.

Apr 2026$12MUK share allotment
Aug 2025$13MUK share allotment
Aug 2024$14MUK share allotment

Founders and team

From Phagenesis's own website: 2 founders, 19 on the team.

Conor MulrooneyCo-Founder & Chief Operating Officer

Shaheen HamdyCo-Founder & Chief Scientific Officer

Andre NelChief Financial Officer
Marc KorenbergChief Financial Officer
Anil KeniVP Global Marketing
Buck WellerVP Sales, US
Cari ManypennyHead of Global Education
Maddy SadiqHead of Human Resources
Nick WoodcockVP Sales, Europe
Scott GrantVP US Therapy Development
Stephen HalsteadHead of QA/RA
Boris DeutschmannDirector European Sales
Chad HoskinsDirector
Drew BurdonDirector
Fred EdeniusDirector
Independent AdvisorDirector
James GibbonsDirector
Michael SjöströmDirector
Michel GardetDirector
Oern StugeChairperson, Director

And 1 more on the team.

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2010Series B2011Series B2013Series D2024Round2024Round2025Round2026

Inventages Venture Capital

EQT Life Sciences

Northern Gritstone

Everyone who backed them

Inventages Venture CapitalVC firm2rounds

EQT Life SciencesVC firm1round

Northern GritstoneVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Phagenesis as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.